AR028248A1 - Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol - Google Patents
Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indolInfo
- Publication number
- AR028248A1 AR028248A1 ARP010101164A ARP010101164A AR028248A1 AR 028248 A1 AR028248 A1 AR 028248A1 AR P010101164 A ARP010101164 A AR P010101164A AR P010101164 A ARP010101164 A AR P010101164A AR 028248 A1 AR028248 A1 AR 028248A1
- Authority
- AR
- Argentina
- Prior art keywords
- tetrahidro
- diazepino
- indol
- new compounds
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18910300P | 2000-03-14 | 2000-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR028248A1 true AR028248A1 (es) | 2003-04-30 |
Family
ID=22695943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010101164A AR028248A1 (es) | 2000-03-14 | 2001-03-13 | Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6734301B2 (es) |
| EP (1) | EP1328525A2 (es) |
| JP (1) | JP2003529569A (es) |
| CN (1) | CN1418216A (es) |
| AR (1) | AR028248A1 (es) |
| AU (2) | AU4316301A (es) |
| CA (1) | CA2402472A1 (es) |
| HK (1) | HK1054740A1 (es) |
| MX (1) | MXPA02008893A (es) |
| NZ (1) | NZ521389A (es) |
| PE (1) | PE20011231A1 (es) |
| WO (1) | WO2001072752A2 (es) |
| ZA (1) | ZA200207341B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0212760A (pt) * | 2001-09-19 | 2004-12-07 | Aventis Pharma Sa | Compostos quìmicos |
| CL2004000826A1 (es) | 2003-04-25 | 2005-03-04 | Pfizer | Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129 |
| CN102060806A (zh) * | 2003-09-11 | 2011-05-18 | iTherX药品公司 | 细胞因子抑制剂 |
| JP5173190B2 (ja) | 2004-08-25 | 2013-03-27 | 武田薬品工業株式会社 | 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法 |
| EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
| WO2009063992A1 (ja) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
| KR20110132564A (ko) * | 2009-02-11 | 2011-12-08 | 선오비온 파마슈티컬스 인코포레이티드 | 히스타민 ｈ3 역 작용제 및 길항제, 및 이의 사용 방법 |
| US20120172350A1 (en) * | 2009-09-11 | 2012-07-05 | Sunovion Pharmaceuticals Inc. | Histamine h3 inverse agonists and antagonists and methods of use thereof |
| US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
| ES2724531T3 (es) | 2011-05-12 | 2019-09-11 | Proteostasis Therapeutics Inc | Reguladores de proteostasis |
| WO2013138753A1 (en) | 2012-03-16 | 2013-09-19 | Fox Chase Chemical Diversity Center, Inc. | Prodrugs of riluzole and their method of use |
| GB201401886D0 (en) | 2014-02-04 | 2014-03-19 | Lytix Biopharma As | Neurodegenerative therapies |
| HU230880B1 (hu) | 2015-04-15 | 2018-11-29 | Richter Gedeon Nyrt | Indol származékok |
| US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3867374A (en) | 1968-06-05 | 1975-02-18 | Mcneilab Inc | Diazepinoindoles |
| US3689503A (en) | 1970-07-30 | 1972-09-05 | Mcneilab Inc | Indole-2-carboxylates |
| SU460724A1 (ru) | 1972-07-24 | 1989-07-30 | Новокузнецкий научно-исследовательский химико-фармацевтический институт | Способ получени 2,3-дигидро-1Н-1,4-диазепино-(4,5-а)индол-2-онов |
| US4210590A (en) | 1978-01-06 | 1980-07-01 | Mcneil Laboratories, Incorporated | Reduction of indole compounds to indoline compounds |
| NL8500370A (nl) | 1984-02-22 | 1985-09-16 | Sandoz Ag | Diazepinoindolen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten. |
-
2001
- 2001-03-08 EP EP01916099A patent/EP1328525A2/en not_active Withdrawn
- 2001-03-08 US US09/803,242 patent/US6734301B2/en not_active Expired - Fee Related
- 2001-03-08 MX MXPA02008893A patent/MXPA02008893A/es unknown
- 2001-03-08 AU AU4316301A patent/AU4316301A/xx active Pending
- 2001-03-08 CN CN01806467A patent/CN1418216A/zh active Pending
- 2001-03-08 CA CA002402472A patent/CA2402472A1/en not_active Abandoned
- 2001-03-08 AU AU2001243163A patent/AU2001243163B2/en not_active Ceased
- 2001-03-08 WO PCT/US2001/004950 patent/WO2001072752A2/en not_active Application Discontinuation
- 2001-03-08 NZ NZ521389A patent/NZ521389A/en unknown
- 2001-03-08 JP JP2001570662A patent/JP2003529569A/ja active Pending
- 2001-03-09 PE PE2001000227A patent/PE20011231A1/es not_active Application Discontinuation
- 2001-03-13 AR ARP010101164A patent/AR028248A1/es unknown
-
2002
- 2002-09-12 ZA ZA200207341A patent/ZA200207341B/xx unknown
-
2003
- 2003-09-11 HK HK03106482.9A patent/HK1054740A1/zh unknown
-
2004
- 2004-01-20 US US10/761,070 patent/US20040209870A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6734301B2 (en) | 2004-05-11 |
| US20040209870A1 (en) | 2004-10-21 |
| US20020002161A1 (en) | 2002-01-03 |
| NZ521389A (en) | 2005-06-24 |
| AU4316301A (en) | 2001-10-08 |
| EP1328525A2 (en) | 2003-07-23 |
| JP2003529569A (ja) | 2003-10-07 |
| CN1418216A (zh) | 2003-05-14 |
| CA2402472A1 (en) | 2001-10-04 |
| WO2001072752A2 (en) | 2001-10-04 |
| PE20011231A1 (es) | 2001-12-06 |
| MXPA02008893A (es) | 2003-02-10 |
| ZA200207341B (en) | 2004-01-21 |
| WO2001072752A3 (en) | 2003-04-17 |
| AU2001243163B2 (en) | 2004-11-04 |
| HK1054740A1 (zh) | 2003-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60216115D1 (de) | BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE | |
| CY2014041I2 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
| DE60131971D1 (de) | 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN | |
| ATE298748T1 (de) | (1,4')-bipiperidin verbindungen | |
| DE60214428D1 (de) | 1, 4-dihydro-1, 4-diphenylpyridin-derivate | |
| DE60225341D1 (de) | Neue 1,2,4-triazolverbindung | |
| ITRM20010537A0 (it) | Motociclo. | |
| ITRM20010523A0 (it) | Motociclo. | |
| AR028248A1 (es) | Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol | |
| DE50107988D1 (de) | Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate | |
| DE60025958D1 (de) | 14,15-beta-methylen substituierte androgene | |
| BR0101022B1 (pt) | motocicleta. | |
| ITTO20020747A1 (it) | Composizione. | |
| ITTO20020005A1 (it) | Motociclo. | |
| DE50214487D1 (de) | Substituierte 1,5-diaminopentan-3-ol-verbindungen | |
| ITTO20010846A0 (it) | Motociclo. | |
| ITTO20020745A1 (it) | Composizione. | |
| ITTO20020348A1 (it) | Motociclo. | |
| IS7131A (is) | Nýjar 2,4-díamínóþíasól afleiður | |
| AR027974A1 (es) | 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas | |
| ES1048400Y (es) | Bota-patin mejorada. | |
| NL1021007A1 (nl) | Beugelslot. | |
| DE60224192D1 (de) | Antihaemorrhagische, betain-enthaltende zusammenseuzungen | |
| IS7299A (is) | 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður | |
| ES1046165Y (es) | Lata mejorada. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |